Second Sight Medical (EYES) Reports Q2 Loss of $0.11

Second Sight Medical (NASDAQ: EYES) reported Q2 EPS of ($0.11), versus ($0.12) reported last year. Revenue for the quarter came in at $1.9 million, versus $2.2 million reported last year.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'